Plasma linoleic acid levels and cardiovascular risk factors: results from the Norwegian ACE 1950 Study

Background A high intake of linoleic acid (LA), the major dietary polyunsaturated fatty acid (PUFA), has previously been associated with reduced cardiovascular (CV) morbidity and mortality in observational studies. However, recent secondary analyses from clinical trials of LA-rich diet suggest harmf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical nutrition 2020-12, Vol.74 (12), p.1707-1717
Hauptverfasser: Chandra, Anupam, Røsjø, Helge, Svensson, My, Vigen, Thea, Ihle-Hansen, Håkon, Orstad, Eivind Bjørkan, Rønning, Ole Morten, Lyngbakken, Magnus Nakrem, Nygård, Ståle, Berge, Trygve, Schmidt, Erik Berg, Omland, Torbjørn, Tveit, Arnljot, Eide, Ivar Anders
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background A high intake of linoleic acid (LA), the major dietary polyunsaturated fatty acid (PUFA), has previously been associated with reduced cardiovascular (CV) morbidity and mortality in observational studies. However, recent secondary analyses from clinical trials of LA-rich diet suggest harmful effects of LA on CV health. Methods A total of 3706 participants, all born in 1950, were included in this cross-sectional study. We investigated associations between plasma phospholipid levels of LA and CV risk factors in a Norwegian general population, characterized by a relative low LA and high marine n-3 PUFA intake. The main statistical approach was multivariable linear regression. Results Plasma phospholipid LA levels ranged from 11.4 to 32.0 wt%, with a median level of 20.8 wt% (interquartile range 16.8–24.8 wt%). High plasma LA levels were associated with lower serum low-density lipoprotein cholesterol levels (standardized regression coefficient [Std. β-coeff.] −0.04, p  = 0.02), serum triglycerides (Std. β-coeff. −0.10, p  
ISSN:0954-3007
1476-5640
DOI:10.1038/s41430-020-0641-4